Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 162 | 317 | 24 | 28 | 39 |
| Cost of Goods | 7 | 8 | N/A | N/A | N/A |
| Gross Profit | 155 | 309 | 24 | 28 | 39 |
| Operating Expenses | 49,793 | 44,557 | 31,166 | 30,306 | 23,134 |
| Operating Income | -49,631 | -44,240 | -31,142 | -30,278 | -23,095 |
| Interest Expense | 3,899 | 1,960 | 1,821 | 1,103 | 864 |
| Other Income | 3,005 | 1,296 | 1,029 | 887 | 572 |
| Pre-tax Income | -50,525 | -44,904 | -31,934 | -30,494 | -23,387 |
| Net Income Continuous | -50,525 | -44,904 | -31,934 | -30,494 | -23,387 |
| Net Income | $-50,525 | $-44,904 | $-31,934 | $-30,494 | $-23,387 |
| EPS Basic Total Ops | -0.21 | -0.22 | -0.17 | -0.17 | -0.13 |
| EPS Basic Continuous Ops | -0.21 | -0.22 | -0.17 | -0.16 | -0.13 |
| EPS Diluted Total Ops | -0.21 | -0.22 | -0.17 | -0.17 | -0.13 |
| EPS Diluted Continuous Ops | -0.21 | -0.22 | -0.17 | -0.16 | -0.13 |
| EBITDA(a) | $-48,862 | $-43,823 | $-30,765 | $-29,830 | $-22,770 |